AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 156 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $108,000 | +33.3% | 36,200 | -33.2% | 0.00% | – |
| Q2 2016 | $81,000 | -62.5% | 54,210 | -6.9% | 0.00% | – |
| Q1 2016 | $216,000 | +380.0% | 58,247 | +1187.2% | 0.00% | – |
| Q4 2015 | $45,000 | -75.7% | 4,525 | -53.5% | 0.00% | – |
| Q2 2015 | $185,000 | -94.6% | 9,739 | -94.0% | 0.00% | -100.0% |
| Q4 2014 | $3,412,000 | -37.2% | 162,936 | +0.0% | 0.00% | -50.0% |
| Q3 2014 | $5,437,000 | +7.7% | 162,857 | +3.5% | 0.00% | +33.3% |
| Q2 2014 | $5,048,000 | +26468.4% | 157,318 | +39229.5% | 0.00% | – |
| Q1 2014 | $19,000 | +1800.0% | 400 | +2400.0% | 0.00% | – |
| Q4 2013 | $1,000 | -99.8% | 16 | -99.7% | 0.00% | – |
| Q3 2013 | $466,000 | -86.7% | 5,438 | -90.2% | 0.00% | -100.0% |
| Q2 2013 | $3,502,000 | – | 55,289 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,637,455 | $42,852,000 | 9.04% |
| Broadfin Capital, LLC | 2,502,578 | $65,492,000 | 5.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 5,349,840 | $140,005,000 | 3.03% |
| HighVista Strategies LLC | 265,110 | $6,938,000 | 1.11% |
| Perceptive Advisors | 381,100 | $9,973,000 | 0.78% |
| Healthcare Value Capital, LLC | 25,000 | $654,000 | 0.71% |
| ADVENT INTERNATIONAL, L.P. | 347,001 | $9,081,000 | 0.70% |
| Birchview Capital, LP | 46,000 | $1,204,000 | 0.63% |
| NORTH TIDE CAPITAL, LLC | 300,000 | $7,851,000 | 0.59% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,323,633 | $60,809,000 | 0.35% |